Download the free whitepaper: Unravelling the complexities of genomics-driven drug discovery

Genomics-driven drug discovery holds immense promise in developing targeted therapies by leveraging genetic and biomarker information to understand the root causes of diseases. However, the field faces significant hurdles.

In this whitepaper, we examine the obstacles of limited recontactability, scarcity of multi-omics data sets, lack of diversity in data, and the challenge of scaling research for rare diseases. By addressing these challenges and proposing strategies to address them, this whitepaper aims to chart a path by which we can harness the full potential of genomics-driven drug discovery.

 

whitepaper image
download icon

Download case study

Accelerating GBA1+ Parkinson’s disease recruitment for a gene therapy trial

How a leading pharmaceutical company partnered with Sano to speed up genetically targeted enrollment

Recruiting individuals with GBA1+ Parkinson’s disease is difficult because of small patient populations, complex eligibility criteria, and hesitation around gene therapy. In this program, a top global pharmaceutical sponsor worked with Sano to move past these barriers and reach key recruitment milestones.

In the first four months, Sano identified genetically eligible participants, maintained strong engagement throughout screening, and supported rapid site activation. The early success of the program led to an expansion of recruitment targets. 

The case study reveals:
✅ How Sano combined database outreach and precision digital recruitment to find the right participants quicker
✅ The operational challenges uncovered early in the process and the steps taken to manage them
✅ A clear view of the recruitment pipeline from sign-up to confirmed GBA1+ referral
✅ The results that prompted the sponsor to increase kit volume and extend the program 

If your team is working on gene therapy or genetically stratified studies, this case study highlights what is possible with an integrated model that brings genetic testing, patient finding, and long term engagement into a single workflow.

Download now to learn more.

groupPD-1